Company / Gross Profit per Share
AMICUS THERAPEUTICS, INC. Gross Profit per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$1.88
FY2025
5-year range
$1.03 / $1.88
FY2021-FY2025
Trend
+15.9%
vs FY2024
Sector context
#22 of 29
Health Care
What the data says
AMICUS THERAPEUTICS, INC.'s gross profit per share of $1.88 is lower than 76% of companies in the Health Care sector (FY2025). Gross Profit per Share has increased for 9 consecutive years, from $0.03 in FY2016 to $1.88 in FY2025.
Based on SEC 10-K filings.
1.88 in FY2025 with a 5-year CAGR of +16.2%.
Improved from $1.29 to $1.88 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +21.7%
- 5-Year CAGR
- +16.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 29This company $1.88 Sector average $8.10
▼
-76.8% below sector average
Key checks
Key Insights
- AMICUS THERAPEUTICS, INC.'s gross profit per share has grown for 9 consecutive years.
- In FY2025, gross profit per share increased 15.9% year-over-year.
- Ranks #22 out of 29 companies in the Health Care sector.
- Lowest gross profit per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.88 | +15.9% |
| FY2024 | $1.62 | +25.7% |
| FY2023 | $1.29 | +23.6% |
| FY2022 | $1.04 | +0.7% |
| FY2021 | $1.03 | +16.5% |
| FY2020 | $0.89 | +33.2% |
| FY2019 | $0.67 | +61.2% |
| FY2018 | $0.41 | +92.3% |
| FY2017 | $0.22 | +552.0% |
| FY2016 | $0.03 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026